Form 4: Exzeo CEO buys 2,000 shares; holds 5M options

Exzeo Group CEO Paresh Patel purchased 2,000 shares at $13.89 under a Rule 10b5-1 plan and now reports 1,590,013 shares owned plus 5,000,000 stock options at a $23 strike expiring 10/01/2031.

Summary

• On 03/27/2026, CEO and Director Paresh Patel purchased 2,000 Exzeo Group, Inc. (XZO) shares at an average price of $13.89 under a Rule 10b5-1 trading plan.
• Following the transaction, direct beneficial ownership stands at 1,590,013 common shares.
• Patel also holds stock options for 5,000,000 shares at a $23 exercise price, expiring on 10/01/2031; vesting occurred 25% on 10/01/2022 and continues in 1/16 increments each Jan 1, Apr 1, Jul 1, and Oct 1 thereafter.
• The report was signed by Brook Baker, Attorney-in-Fact for Paresh Patel, on 03/30/2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as neutral to slightly positive: an insider purchase is supportive, but the trade is small and made under a 10b5-1 plan.

Positives

• Insider open-market purchase by the CEO (2,000 shares at $13.89) signals alignment with shareholders.
• Substantial equity exposure: 1,590,013 directly held shares plus 5,000,000 options ties executive incentives to shareholder value.
• Trade executed under a Rule 10b5-1(c) plan, indicating pre-established trading parameters.

Negatives

• Purchase size is modest relative to existing holdings (~0.13% of reported direct ownership).
• Stock options are out of the money relative to the reported purchase price ($23 strike vs. $13.89 purchase), limiting near-term exercise incentive.

Future Outlook

NA

Management Comments

• On 10/01/2021, an option to purchase 5,000,000 shares was granted; 25% vested on 10/01/2022, with the remaining shares vesting in equal 1/16 installments on each January 1, April 1, July 1, and October 1 thereafter.

Industry Context

StockSavvy.ai notes that insider purchases can be viewed as a confidence signal, but trades executed under Rule 10b5-1 plans are typically pre-arranged and carry weaker signaling value than discretionary buys; the modest size of this purchase suggests a neutral-to-slightly-positive read-through.

Comparison to Industry Standards

• The stock option structure (four-year vesting with quarterly tranches and a 10-year expiration) is standard for U.S. executive equity compensation.
• Open-market insider trades under Rule 10b5-1 are common and are generally interpreted as routine portfolio management rather than strong incremental conviction.
• Given the absence of operating results or financial guidance, there is no direct benchmark comparison to sector peers’ financial performance in this disclosure.

Related Party Transactions

• Executive stock option grant to Paresh Patel on 10/01/2021 for 5,000,000 shares at a $23 exercise price with the stated vesting schedule.

Stakeholder Impact

• Shareholders may interpret the CEO’s open-market buy as a modest confidence signal.
• No dilution results from the open-market purchase; potential future dilution could occur upon exercise of the 5,000,000 options.
• Executive-shareholder alignment is reinforced through significant equity holdings and options.

Next Steps

• Ongoing vesting of the option in 1/16 increments on Jan 1, Apr 1, Jul 1, and Oct 1 until fully vested.
• Potential future exercise of options prior to the 10/01/2031 expiration, subject to market conditions and vesting.

Key Dates

Recommendation

The insider purchase is supportive but small and executed under a pre-arranged 10b5-1 plan, offering limited incremental signal. Large out-of-the-money options indicate long-term alignment but do not change the near-term investment thesis based on this disclosure alone.

Keywords

Exzeo Group, XZO, Paresh Patel, Form 4, insider purchase, Rule 10b5-1, stock options, beneficial ownership, CEO, open market buy